Finance

Lists
CHEK:IDX
Diastika Biotekindo Tbk PT
119,00 IDR
-1,65%
(-2,00) 1D
15 ოქტ, 16:03:47 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for CHEK...
Open
120 IDR
High
122 IDR
Low
118 IDR
Mkt. cap
489,49 მლრ.
Avg. vol.
1,88 მლნ.
Volume
250,90 ათ.
P/E ratio
13,77
52-wk high
194 IDR
52-wk low
111 IDR
EPS
9 IDR
Shares outstanding
4,11 მლრდ.
No. of employees
123
Open
120 IDR
High
122 IDR
Low
118 IDR
Mkt. cap
489,49 მლრ.
Avg. vol.
1,88 მლნ.
Volume
250,90 ათ.
P/E ratio
13,77
52-wk high
194 IDR
52-wk low
111 IDR
EPS
9 IDR
Shares outstanding
4,11 მლრდ.
No. of employees
123
News stories
From web sources and news partners
About Diastika Biotekindo Tbk PT
CEO-
Employees123
Founded1989
Headquarters-
SectorHealth care provider
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
53,43 მლრდ.
69,56 მლრდ.
37,27 მლრდ.
45,01 მლრდ.
Cost of goods sold
31,60 მლრდ.
47,95 მლრდ.
21,86 მლრდ.
25,83 მლრდ.
Cost of revenue
31,60 მლრდ.
47,95 მლრდ.
21,86 მლრდ.
25,83 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,99 მლრდ.
13,45 მლრდ.
14,30 მლრდ.
16,02 მლრდ.
Operating expense
14,93 მლრდ.
15,29 მლრდ.
14,30 მლრდ.
16,02 მლრდ.
Total operating expenses
46,54 მლრდ.
63,24 მლრდ.
36,16 მლრდ.
41,85 მლრდ.
Operating income
6,89 მლრდ.
6,32 მლრდ.
1,11 მლრდ.
3,16 მლრდ.
Other non operating income
1,84 მლრდ.
-2,11 მლრდ.
10,58 მლნ.
124,11 მლნ.
EBT including unusual items
8,98 მლრდ.
4,17 მლრდ.
686,59 მლნ.
2,81 მლრდ.
EBT excluding unusual items
8,89 მლრდ.
4,26 მლრდ.
686,59 მლნ.
2,81 მლრდ.
Income tax expense
-
4,38 მლრდ.
-
-
Effective tax rate
-
105,01%
-
-
Other operating expenses
-58,75 მლნ.
1,84 მლრდ.
-
-
Net income
8,98 მლრდ.
-209,18 მლნ.
686,59 მლნ.
2,81 მლრდ.
Net profit margin
16,80%
-0,30%
1,84%
6,25%
Earnings per share
-
-
-
-
Interest and investment income
191,96 მლნ.
1,55 მლრდ.
290,70 მლნ.
914,01 მლნ.
Interest expense
-29,15 მლნ.
-
-725,65 მლნ.
-1,38 მლრდ.
Net interest expenses
162,81 მლნ.
1,55 მლრდ.
-434,94 მლნ.
-467,91 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
8,79 მლრდ.
9,65 მლრდ.
5,43 მლრდ.
7,61 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები